{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/43386-050#drug","name":"GAVILYTE-N","alternateName":"polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"43386-050"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA090019"},{"@type":"PropertyValue","propertyID":"UNII","value":"G2M7P15E5P|660YQ98I10|8MDF5V39QO|451W47IQ8X"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"27195187-75a3-431f-90d9-84da1b94e849"}],"activeIngredient":"POLYETHYLENE GLYCOL 3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE","administrationRoute":["ORAL"],"dosageForm":"POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Lupin Pharmaceuticals,Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA090019","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27195187-75a3-431f-90d9-84da1b94e849","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43386-050"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T02:33:05.783Z"}}